The Alberta hip and knee replacement project: A model for health technology assessment based on comparative effectiveness of clinical pathways

International Journal of Technology Assessment in Health Care

Volumn 25, Issue 2, 2009, Pages 113-123

  Gooch, Katherine L ^a   Smith, Douglas ^b   Wasylak, Tracy ^c   Faris, Peter D ^d   Marshall, Deborah A ^d,e   Khong, Hoa ^b   Hibbert, Julie E ^b   Parker, Robyn D ^b   Zernicke, Ronald F ^f,g   Beaupre, Lauren ^c,h   Pearce, Tim ^c   Johnston, D W C ^c   Frank, Cyril B ^b,d  

^a CURTIN UNIVERSITY   (Australia)

^b Alberta Bone and Joint Health Institute   (Canada)

^c ALBERTA HEALTH SERVICES   (Canada)

^d UNIVERSITY OF CALGARY   (Canada)

^e Health Technology Assessment   (Canada)

^f Department of Biomedical Engineering

^g UNIVERSITY OF MICHIGAN   (United States)

^h UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Arthroplasty; Clinical pathways; Health technology assessment; Outcome measures; Pragmatic randomized controlled trial; Quality indicators

Indexed keywords

ARTHROPLASTY; CLINICAL PATHWAYS; HEALTH TECHNOLOGY ASSESSMENT; OUTCOME MEASURES; PRAGMATIC RANDOMIZED CONTROLLED TRIAL; QUALITY INDICATORS;

CUSTOMER SATISFACTION; DESIGN; HEALTH; JOINT PROSTHESES; PATIENT REHABILITATION; PROGRAMMABLE LOGIC CONTROLLERS; SURGERY; TECHNOLOGICAL FORECASTING; TECHNOLOGY;

QUALITY CONTROL;

ADULT; AGED; ARTICLE; CANADA; CLINICAL PATHWAY; CLINICAL PRACTICE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEMOGRAPHY; EVIDENCE BASED MEDICINE; FEASIBILITY STUDY; FEMALE; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HIP ARTHROPLASTY; HUMAN; KNEE ARTHROPLASTY; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; METHODOLOGY; ORTHOPEDICS; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT REFERRAL; QUALITY OF LIFE; QUALITY OF LIFE INDEX; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; BIOMEDICAL TECHNOLOGY ASSESSMENT; COMPARATIVE STUDY; HEALTH SERVICES RESEARCH; MIDDLE AGED; MULTICENTER STUDY; STANDARD; TREATMENT OUTCOME;

AGED; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; CRITICAL PATHWAYS; EVIDENCE-BASED MEDICINE; FEMALE; HEALTH SERVICES RESEARCH; HUMANS; MALE; MIDDLE AGED; QUALITY INDICATORS, HEALTH CARE; QUALITY OF LIFE; TECHNOLOGY ASSESSMENT, BIOMEDICAL; TREATMENT OUTCOME;

EID: 67549107545     PISSN: 02664623     EISSN: 14716348     Source Type: Journal    
DOI: 10.1017/S0266462309090163     Document Type: Article

References (48)

1. Aaronson NK, Acquadro C, Alonso J, et al. International quality of life assessment (IQOLA) project. Qual Life Res. 1992;1:349-351.
2. Agency for Healthcare Research & Quality. US Department of Health & Human Services. National Guideline Clearinghouse. www.guideline.gov (accessed December 18, 2008).
3. Alberta Regional Health Authorities. The careguide source for seniors. www.thecareguide.com/Resources (accessed November 14, 2008).
4. Australian Orthopaedic Association. National Joint Replacement Registry Annual Report 2007. http://www.dmac. adelaide.edu.au/aoanjrr/documents/ aoanjrrreport-2007.pdf (accessed November 23, 2008).
5. Bellamy N. WOMAC osteoarthritis index- user guide VII. Brisbane, Australia: 2004.
6. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: A health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988;15:1833-1840.
7. Berry DJ, Harmsen WS, Cabanela ME, Morrey BF. Twenty- five-year survivorship of two thousand consecutive primary Charnley total hip replacements: Factors affecting survivorship of acetabular and femoral components. J Bone Joint Surg Am. 2002;84:171-177.
8. Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P, CONSORT Group. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: Explanation and elaboration. Ann Intern Med. 2008;148:295-309.
9. Brunenberg DE van Steyn MJ, Sluimer JC, et al. Joint recovery programme versus usual care: An economic evaluation of a clinical pathway for joint replacement surgery. Med Care. 2005;43:1018-1026.
10. Canadian Institute of Health Information (CIHI). Canadian Joint Replacement Registry (CJRR) 2006 annual report. Hip and knee replacements in Canada 2006. http://dsppsd. pwgsc.gc.ca/Collection/H115-7-2006E.pdf.
11. Clark DO, Von Korff M, Saunders K, Baluch WM, Simon GE. A chronic disease score with empirically derived weights. Med Care. 1995;33:783-795.
12. Cushnaghan J, Bennett J, Reading I, et al. Long-term outcome following total knee arthroplasty: A controlled longitudinal study. Ann Rheum Dis. 2008 [Epub ahead of print].
13. Darer J, Pronovost P, Bass EB. Use and evaluation of critical pathways in hospitals. Eff Clin Pract. 2002;5:114-119.
14. Dixon T, Shaw ME, Dieppe PA. Analysis of regional variation in hip and knee joint replacement rates in England using hospital episodes statistics. Public Health. 2006;120:83-90.
15. Dowsey MM, Kilgour ML, Santamaria NM, Choong PF. Clinical pathways in hip and knee arthroplasty: A prospective randomised controlled study. Med J Aust. 1999;170:59-62.
16. Dy SM, Garg P, Nyberg D, et al. Critical pathway effectiveness: Assessing the impact of patient, hospital care, and pathway characteristics using qualitative comparative analysis. Health Serv Res. 2005;40:499-516.
17. El Baz N, Middel B, van Dijk JP, et al. Are the outcomes of clinical pathways evidence-based? A critical appraisal of clinical pathway evaluation research. J Eval Clin Pract. 2007;13:920-929.
18. Ernst E, Canter PH. Limitations of "pragmatic" trials. Postgrad Med J. 2005;81:203.
19. Freemantle N, Blonde L, Bolinder B, et al. Real-world trials to answer real-world questions. Pharmacoeconomics. 2005;23:747-754.
20. Garrison LP Jr, Neumann PJ, Erickson P, Marshall D, Mullins CD. Using real-world data for coverage and payment decisions: The ISPOR real-world data task force report. Value Health. 2007;10:326-335
21. Glasgow RE, Magid DJ, Beck A, Ritzwoller D, Estabrooks PA. Practical clinical trials for translating research to practice: Design and measurement recommendations. Med Care. 2005;43:551-557.
22. Health Quality Council of Alberta. Alberta Quality Matrix for Health (AQMH) user guide 2005. http://www.hqca. ca/index.php.
23. Healy WL, Ayers ME, Iorio R, et al. Impact of a clinical pathway and implant standardization on total hip arthroplasty: A clinical and economic study of short-term patient outcome. J Arthroplasty. 1998;13:266-276.
24. Jain NB, Higgins LD, Ozumba D, et al. Trends in epidemiology of knee arthroplasty in the United States, 1990-2000. Arthritis Rheum. 2005;52:3928-3933.
25. Joint Replacement Unit, Sahlgrenska University Hospital. Swedish Hip Arthroplasty Register annual report 2006. www.jru.orthop.gu.se (accessed November 21, 2008).
26. Lin YK, Su JY, Lin GT, et al. Impact of a clinical pathway for total knee arthroplasty. Kaohsiung J Med Sci. 2002;18:134-140.
27. Lingard EA, Berven S, Katz JN, Kinemax Outcomes Group. Management and care of patients undergoing total knee arthroplasty: Variations across different health care settings. Arthritis Care Res. 2000;13:129-136.
28. Macario A, Horne M, Goodman S, et al. The effect of a perioperative clinical pathway for knee replacement surgery on hospital costs. Anesth Analg. 1998;86:978-984.
29. Macdonald SJ, Charron KD, Bourne RB, et al. The John Insall Award: Gender-specific total knee replacement: Prospectively collected clinical outcomes. Clin Orthop Relat Res. 2008;466:2612-2616.
30. Macpherson H. Pragmatic clinical trials. Complement Ther Med. 2004;12:136-140.
31. McMahon AD. Study control, violators, inclusion criteria and defining explanatory and pragmatic trials. Stat Med. 2002;21:1365-1376.
32. National Health Services Scotland. Scottish Arthroplasty Project annual report 2008. http://www.arthro.scot.nhs.uk/ Reports/Main.html (accessed November 23, 2008).
33. Panella M, Marchisio S, Di Stanislao F. Reducing clinical variations with clinical pathways: Do pathways work? Int J Qual Health Care. 2003;15:509-521.
34. Pearson SD, Kleefield SF, Soukop JR, Cook EF, Lee TH. Critical pathways intervention to reduce length of hospital stay. Am J Med. 2001;110:175-180.
35. Pennington JM, Jones DP, McIntyre S. Clinical pathways in total knee arthroplasty: A New Zealand experience. J Orthop Surg (Hong Kong). 2003;11:166-173.
36. Renholm M, Leino-Kilpi H, Suominen T. Critical pathways. A systematic review. J Nurs Adm. 2002;32:196-202.
37. Rissanen P, Aro S, Sintonen H, Slatis P, Paavolainen P. Quality of life and functional ability in hip and knee replacements: A prospective study. Qual Life Res. 1996;5:56-64.
38. Roland M, Torgerson DJ. What are pragmatic trials? BMJ. 1998;316:285.
39. Roos EM. Effectiveness and practice variation of rehabilitation after joint replacement. Curr Opin Rheumatol. 2003;15:160-162.
40. Schwartz D, Lellouch J. Explanatory and pragmatic attitudes in therapeutical trials. J Chronic Dis. 1967;20:637-648.
41. Teutsch SM, Berger ML, Weinstein MC. Comparative effectiveness: Asking the right questions, choosing the right method. Health Aff (Millwood). 2005;24:128-132.
42. Tunis SR, Stryer DB, Clancy CM. Practical clinical trials: Increasing the value of clinical research for decision making in clinical and health policy. JAMA. 2003;290:1624-1632.
43. Vanhaecht K, Sermeus W, Tuerlinckx G, et al. Development of a clinical pathway for total knee arthroplasty and the effect on length of stay and in-hospital functional outcome. Acta Orthop Belg. 2005;71:439-444.
44. Walter FL, Bass N, Bock G, Markel DC. Success of clinical pathways for total joint arthroplasty in a community hospital. Clin Orthop Relat Res. 2007;457:133-137.
45. Wertheimer AI. The defined daily dose system (DDD) for drug utilization review. Hosp Pharm. 1986;21:233-234, 239-241, 258.
46. WHO Collaborating Centre for Drug Statistics Methodology. ATC/DDD applications. http://www.whocc.no/atcddd/ (accessed January 16, 2009).
47. Wilensky GR. Developing a center for comparative effectiveness information. Health Aff (Millwood). 2006;25:w572-w585. (Pubitemid 44871704)
48. Zwarenstein M, Treweek S, Gagnier JJ, et al. Improving the reporting of pragmatic trials: An extension of the CONSORT statement. BMJ. 2008;337:a2390.a